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VAChT overexpression increases
acetylcholine at the synaptic cleft and
accelerates aging of neuromuscular
junctions
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Ligia A. Naves6, Vania F. Prado7, Marco A. M. Prado7, Cristina Guatimosim5 and Gregorio Valdez1,2*
Abstract
Background: Cholinergic dysfunction occurs during aging and in a variety of diseases, including amyotrophic
lateral sclerosis (ALS). However, it remains unknown whether changes in cholinergic transmission contributes to
age- and disease-related degeneration of the motor system. Here we investigated the effect of moderately
increasing levels of synaptic acetylcholine (ACh) on the neuromuscular junction (NMJ), muscle fibers, and
motor neurons during development and aging and in a mouse model for amyotrophic lateral sclerosis (ALS).
Methods: Chat-ChR2-EYFP (VAChTHyp) mice containing multiple copies of the vesicular acetylcholine transporter
(VAChT), mutant superoxide dismutase 1 (SOD1G93A), and Chat-IRES-Cre and tdTomato transgenic mice were used in
this study. NMJs, muscle fibers, and α-motor neurons’ somata and their axons were examined using a light microscope.
Transcripts for select genes in muscles and spinal cords were assessed using real-time quantitative PCR. Motor function
tests were carried out using an inverted wire mesh and a rotarod. Electrophysiological recordings were collected to
examine miniature endplate potentials (MEPP) in muscles.
Results: We show that VAChT is elevated in the spinal cord and at NMJs of VAChTHyp mice. We also show that
the amplitude of MEPPs is significantly higher in VAChTHyp muscles, indicating that more ACh is loaded into
synaptic vesicles and released into the synaptic cleft at NMJs of VAChTHyp mice compared to control mice. While
the development of NMJs was not affected in VAChTHyp mice, NMJs prematurely acquired age-related structural
alterations in adult VAChTHyp mice. These structural changes at NMJs were accompanied by motor deficits in
VAChTHyp mice. However, cellular features of muscle fibers and levels of molecules with critical functions at the
NMJ and in muscle fibers were largely unchanged in VAChTHyp mice. In the SOD1G93A mouse model for ALS, increasing
synaptic ACh accelerated degeneration of NMJs caused motor deficits and resulted in premature death specifically in
male mice.
Conclusions: The data presented in this manuscript demonstrate that increasing levels of ACh at the synaptic cleft
promote degeneration of adult NMJs, contributing to age- and disease-related motor deficits. We thus propose that
maintaining normal cholinergic signaling in muscles will slow degeneration of NMJs and attenuate loss of motor
function caused by aging and neuromuscular diseases.
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Background
The organization and stability of synapses is dictated by
the actions of pre- and postsynaptic organizing mole-
cules, including neurotransmitters [1–3]. The vertebrate
neuromuscular junction (NMJ), the synapse formed be-
tween α-motor neurons and skeletal muscle fibers, is
under the influence of the neurotransmitter acetylcho-
line (ACh) [1]. In addition to promoting muscle contrac-
tion, several lines of evidence indicate that ACh acts as
an anti-synaptogenic factor [4, 5]. ACh promotes disper-
sion of nicotinic acetylcholine receptors (AChR) from
postsynaptic sites by inducing posttranslational changes
and accelerating the endocytosis of AChRs [6]. In mice
lacking ACh, developing muscles contain larger and
more complex postsynaptic sites that are innervated by
silent motor axons. These postsynaptic sites initially
form but fail to mature in the absence of neural-derived
agrin (z-agrin), a molecule with critical roles in stabiliz-
ing AChRs [7, 8]. These findings have led to the hypoth-
esis that ACh acts in concert with z-agrin in sculpting
and stabilizing postsynaptic sites [7].
The recent generation of transgenic mice with altered
expression of the vesicular acetylcholine transporter
(VAChT) has made it possible to examine the impact of
varying levels of ACh throughout the lifespan of mice
[9, 10]. VAChT functions to load ACh into synaptic
vesicles, thereby regulating the amount of neurotrans-
mitter released [11]. Young adult mice with reduced
expression of VAChT (VAChTKD) have reduced choliner-
gic neurotransmission [10] while mice overexpressing
VAChT (ChAT–ChR2–EYFP; herein called VAChTHyp)
[12, 13] release more ACh at cholinergic synapses and
thus have heightened cholinergic transmission [9]. Both
transgenic lines exhibit cognitive deficits, indicating that
cholinergic circuits in the brain are highly sensitive to
both increasing and decreasing synaptic ACh. In the lower
motor system, decreasing synaptic ACh by approximately
70 %, as is the case in VAChTKD mice, results in symp-
toms resembling myasthenia gravis [10]. These mice also
exhibit moderate changes in the shape and distribu-
tion of synaptic vesicles in α-motor axon nerve end-
ings [14]. Conversely, young adult VAChTHyp mice
have enhanced motor endurance consistent with in-
creased cholinergic tone [9].
During aging and throughout the progression of amyo-
trophic lateral sclerosis (ALS), neuromuscular function
decreases suggesting that increasing the release of ACh
may potentially preserve muscle tone [1, 15]. Here we
used VAChTHyp mice to determine the contribution of
chronically increasing synaptic ACh levels on develop-
ing, aging, and ALS-afflicted NMJs. We discovered that
NMJs prematurely acquire age-related structural alter-
ations in VAChTHyp mice. These structural changes at
NMJs are accompanied by a moderate reduction in the size
of muscle fibers and motor deficits in aged VAChTHyp
mice. To determine if increased cholinergic transmission
affects the progression of ALS-like pathology, we examined
SOD1G93A mice overexpressing VAChT. Increasing cholin-
ergic transmission selectively affected male SOD1G93A
mice, prematurely causing motor deficits, degeneration of
NMJs, and accelerating death of these mice. Together,
these findings demonstrate that increasing cholinergic
transmission accelerates the degeneration of NMJs during
aging and progression of ALS-like pathology in a mouse
model of the disease.
Methods
Mice
Several transgenic lines were used in these experi-
ments. We obtained the following lines from The
Jackson Laboratory: VAChTHyp (B6.Cg-Tg(Chat-COP4*
H134R/EYFP,Slc18a3)6Gfng/J) [13], SOD1G93A (B6.Cg-
Tg(SOD1*G93A)1Gur/J) [16], ChAT-IRES-Cre (B6;129
S6-Chat < tm1(cre)Lowl>/J) [17], tdTomato (B6;129S6-
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J) [18]. Mice over-
expressing VAChT [13] contained several bacterial
artificial chromosomes (BAC) modified to express
channelrhodopsin from the ChAT locus. However, the
BAC construct used to generate these transgenic mice
also contained an intact VAChT locus, thus introducing
additional functional copies of the VAChT gene. All trans-
genic mice overexpressing VAChT (VAChTHyp) [13] were
maintained as heterozygous and allowed free access to
food and water. For histological and biochemical analysis
of NMJs, muscle fibers, motor neurons, and motor axons,
we used at least four mice per genotype per experiment.
All experiments were carried out under NIH guidelines
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and animal protocols approved by the Virginia Tech Insti-
tutional Animal Care and Use Committee.
Electrophysiological recordings
We recorded miniature endplate potentials (MEPPs)
using an Axoclamp 2A amplifier. Recordings were band-
passed filtered at 0.1 to 5 kHz, further amplified 50
times by a Cyberamp, and then sampled on a computer
at a frequency of 100 kHz. Microelectrodes were fabri-
cated from borosilicate glass using a Narishige puller
(PN-30) and had resistances of 8–15 Mohms when filled
with 3 M KCl. The microelectrodes were inserted into
the muscle fiber in the endplate region to record MEPPs.
Tetrodotoxin (100 nM) was added to the bath solution
to prevent muscle contraction. The signals were digitized
by a board from National Instruments (NIDAQ-MX) and
acquired by the program WinEDR (John Dempster, Uni-
versity of Strathclyde). MEPP amplitudes were corrected
to a standard resting potential of −70 mV. Approximately
100 MEPPs in five different synapses per muscle were an-
alyzed. We used three muscles from three different ani-
mals per genotype at 4 months of age.
Immunohistochemistry and histological analysis under
confocal microscopy
Imaging NMJs
Mice were anesthetized with isoflurane and perfused
transcardially with 4 % paraformaldehyde in phosphate
buffered saline (PBS). The extensor digitorum longus
(EDL) muscle was then dissected. Whole muscles were
blocked for 1 h at room temperature (blocking solution;
1 % Triton X-100, 3 % BSA, 5 % goat serum in PBS) and
then incubated with primary antibodies for 24 h in
blocking solution to visualize AChRs, axons, and synap-
tic vesicles. Following staining with primary antibodies,
muscles were washed three times with PBS-T (0.1 % Tri-
ton X-100) and incubated for 2 h with Alexa 488 or 555
conjugated α-bungarotoxin (fBTX, Life Technologies;
1:1000) and secondary antibodies. After washing with
PBS-T, the muscles were whole-mounted onto slides
using Vectashield (Vector Labs). The primary antibodies
used were synaptotagmin-2 (znp-1, Zebrafish Inter-
national Resource Center; 1:100) and VAChT (Millipore;
1:250). The secondary antibodies used were Alexa-647
anti-mouse IgG2a (Life Technologies; 1:1000) and Alexa-
647 anti-guinea pig IgG (Life Technologies; 1:1000).
NMJ analysis
To analyze structural features at NMJs, maximum inten-
sity projections of confocal stacks were created using
ZEN software (Zeiss). We analyzed structural features
following the criteria previously described by Valdez
et al. [19]. Briefly, fragmented AChRs are defined as five
or more AChR clusters in small islands with round
shape and/or a segment of the postsynapse. It also in-
cludes NMJs with small and/or irregularly shaped AChR
clusters. Full or partial denervation describes postsynaptic
sites not appropriately opposed by the nerve terminal.
Multiple innervations are the simultaneous innervation of
the postsynapse by two or more axons. A nerve sprout oc-
curs when the nerve extends beyond AChR clusters in any
direction. Colocalization is the extent of pre- and postsyn-
aptic apposition measured using ZEN software. To quan-
tify the size of NMJs, the region occupied by AChRs was
measured using ImageJ software.
Fluorescence intensity analysis
To analyze the fluorescence intensity of VAChT immu-
nostaining at NMJs, maximum intensity projections of
confocal stacks were created using ZEN software (Zeiss).
Using Zen Black software (Zeiss), individual NMJs were
outlined and the mean fluorescence intensity was deter-
mined by Zen Black software with background fluores-
cence subtracted. The mean fluorescence intensity for
individual NMJs was averaged to find the overall fluores-
cence intensity for each animal.
Muscle fiber diameter/central nuclei
The tibialis anterior (TA) muscle was dissected from
perfused mice, transferred into a 30 % sucrose solution
for 2 days, and cut using a cryostat at 14-μm thickness.
To visualize muscle fiber size and location of nuclei, the
sections were stained by first blocking for 1 h at room
temperature (0.1 % Triton X-100, 3 % BSA, 5 % goat
serum in PBS) and then incubated with an antibody
against laminin (L9393, Sigma; 1:100) for 24 h in block-
ing solution. The sections were washed three times in
PBS and incubated for 3 h with secondary antibodies
(Alexa-568 anti-rabbit IgG, Life Technologies; 1:1000).
After washing with PBS, sections were incubated with
4′,6-diamidino-2-phenylindole (DAPI; Sigma; 1:1000),
washed with PBS, and mounted using Vectashield. The
area outlined by laminin was measured using ImageJ
software. At least 300 muscle fibers per mouse were ran-
domly selected and used for this analysis. Myonuclei lo-
cated in the center of muscle fibers were counted. At
least 1000 nuclei per mouse were counted.
Nerve counts
To visualize motor axons, Chat-Cre;tdTom mice were
used. The peroneal nerve was dissected from perfused
mice and embedded in a tissue-freezing medium (Tissue-
Tek). The specimens were cut in a cryostat at 10-μm
thickness. Sections were blocked for 1 h at room
temperature (0.1 % Triton X-100, 3 % BSA, 5 % goat
serum in PBS) and subsequently incubated with antibodies
for both neurofilament (smi-312, Covance; 1:1000) and S-
100 (Z0311, Dako; 1:400) for 24 h in blocking solution.
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Sections were then washed three times with PBS for
5 min each and incubated with secondary antibodies
(Alexa-488 anti-mouse IgG1, Alexa-647 anti-rabbit IgG,
Life Technologies; 1:1000). After washing with PBS, sec-
tions were mounted in Vectashield. Axons expressing
tdTom and neurofilament were counted as motor axons.
Axons labeled with only neurofilament are sensory axons.
Expression analysis using quantitative PCR
Mice were first anesthetized with isoflurane, and then
the muscles and spinal cord regions, including cervical,
thoracic, lumbar, and sacral regions, were dissected and
flash frozen in liquid nitrogen. Total RNA was prepared
using Aurum Total RNA Mini kit (Bio-Rad) following
the manufacturer’s instructions. Complementary DNA
(cDNA) was synthesized from 500 ng of total RNA using
the iScript cDNA synthesis kit (Bio-Rad). PCR amplifica-
tion was performed on the Bio-Rad CFX Connect Real-
Time System (Bio-Rad) using iTaq Universal SYBR
Green Supermix (Bio-Rad). All primers used in this
study are listed in Table 1.
SOD1G93A copy number analysis
DNA isolation was performed with the DNeasy Blood
and tissue kit (Qiagen). Changes in transgene copy num-
bers were evaluated using TaqMan probe-based quanti-
tative real-time PCR by determining the difference in
threshold cycle (ΔCT) between the transgene (hSOD1)
and an internal positive control gene. Primers for
hSOD1 were as follows: IMR9665 or Forward = 5′-GG
GAAGCTGTTGTCCCAAG-3′; and IMR9666 or Re-
verse = 5′-CAAGGGGAGGTAAAAGAGAGC-3′. The
TaqMan probe used for hSOD1 is 13854 = 5′-CTGC
ATCTGGTTCTTGCAAAACACCA-3′. The primers for
the internal positive control gene were as follows:
IMR1544 or Forward = 5′-CACGTGGGCTCCAGC
ATT-3′; and IMR3580 or Reverse = 5′-TCACCAGTC
ATTTCTGCCTTTG-3′. The TaqMan probe for the in-
ternal positive control gene is TmoIMR0105 = 5′-CCA
ATGGTCGGGCACTGCTCAA-3′. These primers and
probes are described in the Jackson Laboratories proto-
col for genotyping hSOD1 transgenic mice. We made
minor modifications to the protocol to compare levels of
hSOD1 between mice. We used 5 ng of genomic DNA,
the TaqMan Universal PCR Mastermix (Thermo Fisher
Scientific), and the Bio-Rad CFX Connect Real-Time
System (Bio-Rad) to amplify hSOD1. The following PCR
settings were used: 50 °C for 2 min, 95 °C for 10 min, 40
PCR cycles of 95 °C for 15 s, 60 °C for 1 min. To deter-
mine relative copy numbers, we compared the ΔCT
value between SOD1G93A and SOD1G93A;VAChTHyp for
hSOD1 after subtracting the CT value of the internal
control gene for each sample. The same ΔCT value indi-
cates that there is no difference in the number of hSOD1
between SOD1G93A and SOD1G93A;VAChTHyp mice.
Behavioral tests
Hanging test
We examined motor function using an inverted grid
hanging test [20]. The mice were placed on the center of
a wire grid, which was mounted 25 cm above the table.
After gently inverting the wire grid, we recorded the
time the mouse remained hanging from the wire mesh.
Each mouse was tested three times with at least 5-min
breaks between trials. When comparing the ability of
mice to stay on the wire mesh, we only used the max-
imum time they spent hanging for each trial.
Rotarod test
Mice were placed on a rotarod (Ugo Basile Instruments).
The time that the mice were able to spend on the rotat-
ing platform was recorded. The following settings were
used: for 400-day-old VAChTHyp and wild-type mice, ac-
celeration was set to 8.0 rpm/min with no reverse. The
maximum speed was set to 50 rpm and the minimum
speed was 4 rpm. To test motor function in SOD1G93A
mice, acceleration was set to 5.0 rpm/min with no re-
verse. The maximum speed was set to 80 rpm and the
minimum speed was 2 rpm. Each mouse was tested
three times with at least 5-min breaks between trials.
When comparing the ability of mice to stay on the
Table 1 PCR primers
Gene Fw (5′–3′) Rv (5′–3′)
GAPDH CCCACTCTTCCACCTTCGATG GTCCACCACCCTGTTGCTGTAG
AChE CTACACCACGGAGGAGAGGA CTGGTTCTTCCAGTGCACCA
AChRγ GCTCAGCTGCAAGTTGATCTC CCTCCTGCTCCATCTCTGTC
AChRε GCTGTGTGGATGCTGTGAAC GCTGCCCAAAAACAGACATT
MuSK CCACACTGCGTGGAATGAGC CTCTGCAAATGGGCATGGG
LRP4 GGCAAAAAGCAGGAACTTGT TCTACCCAGTGGCCAGAACT
Rapsyn GTGCCATGGAGTGTTGTGAG CGGTTTCCGATCTCAGTCAT
Dok7 GGGTACTGGGCTGGAGTCTT TCGGACGATGCAGTCAAACA
CDK5 GCCAGACTATAAGCCCTACCC GTCAGAGAAGTAGGGGTGCT
MyHC2A GAGTGAGCAGAAGCGGAATGCT GCGGAACTTGGATAGATTTGTG
MyHC2B CACCTGGACGATGCTCTCAGA GCTCTTGCTCGGCCACTCT
MyHC2X GCTAGTAACATGGAGGTCA TAAGGCACTCTTGGCCTTTATC
Myogenin GCACTGGAGTTCGGTCCCA GTGATGCTGTCCACGATGGA
Foxo1 GAGTTAGTGAGCAGGCTACATTT TTGGACTGCTCCTCAGTTCC
Atrogin-1 GCAGCAGCTGAATAGCATCCA GGTGATCGTGAGGCCTTTGAA
Agrin-8 CTTTGATGGGCGGACCTACA CGCTTTCTCAGCTGGGATCT
Agrin-11 CAGTGGGGGACCTAGAAACAC TTTCAGGGCTCTCAGTCACAG
Agrin-19 CTTTGATGGGCGGACCTACA AGTTTCAGGGGCTGGGATCT
Chat CCTGGATGGTCCAGGCACT GTCATACCAACGATTCGCTCC
VAChT GAGAGTACTTTGCCTGGGAGGA GGCCACAGTAAGACCTCCCTTG
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rotarod, we only used the maximum time they spent on
the rotating platform for each trial.
At least eight animals were tested on both the rotarod
and hanging tests. To compare motor function between
young adult mice, 5-month-old male wild-type and
VAChTHyp mice were used. To compare motor function
between middle-aged mice, 13-month-old female wild-
type mice and VAChTHyp mice were examined. We ex-
amined male mice expressing SOD1G93A.
Analysis of survival rates
All mice affected with ALS were regularly observed.
Mice were euthanized when they were unable to right
themselves back up after lying on their sides. A Kaplan–
Meier log rank test was used to compare the lifespan be-
tween the groups of mice affected with ALS.
Statistical analysis
Student’s t test and a one-way ANOVA followed by
Tukey–Kramer and Kolmogorov-Smirnov tests were
used to compare differences between groups. Data were
expressed as the mean ± SE (standard error). P < 0.05
was considered statistically significant.
Results
VAChT is increased at NMJs of VAChTHyp mice
To assess the impact of altering acetylcholine (ACh)
levels on the neuromuscular system, we examined a
transgenic mouse line with increased expression of the
vesicular acetylcholine transporter (VAChT) gene
(ChAT–ChR2–EYFP [9, 21]; herein called VAChTHyp).
These mice have been shown to release threefold more
synaptic ACh in the brain [9]. In this study, we only ex-
amined VAChTHyp heterozygous mice. We first con-
firmed that VAChT is expressed at higher levels in the
spinal cord of VAChTHyp heterozygous mice using quan-
titative PCR (qPCR). As expected, we found VAChT
messenger RNA (mRNA) significantly increased in the
spinal cord of VAChTHyp mice compared to litter mate
controls (Fig. 1a). We next used immunohistochemistry
to examine the concentration of VAChT protein at
neuromuscular junctions (NMJs) in the extensor digi-
torum longus (EDL) muscle. NMJs were visualized using
fluorescently tagged α-bungarotoxin (fBTX), which binds
selectively to nicotinic acetylcholine receptors (AChRs)
located on the postsynaptic region of the NMJ. Using the
same scanning parameters, VAChT immunofluorescence
was invariably more intense at NMJs of VAChTHyp mice
(Fig. 1c-d) compared to NMJs of control mice (Fig. 1b, d).
Miniature endplate potential amplitudes are increased in
VAChTHyp muscles
To determine the impact of overexpressing VAChT on
quantal size, we measured miniature endplate potentials
(MEPPs) in the diaphragm muscle from 4-month-old
controls and from VAChTHyp mice. While the frequency
of MEPPs was unchanged (Fig. 2a), the amplitude of
MEPPs was significantly higher in VAChTHyp compared
to control mice (Fig. 2b, c). The mean MEPP amplitude
was 0.86 ± 0.12 (mean ± SEM per muscle fibers per ani-
mal) mV in control mice (median = 0.75 mV) and 1.235
± 0.18 mV in VAChTHyp mice (median = 1.244 mV). We
also found that the frequency of large mini amplitudes
increased in VAChTHyp mice (Fig. 2c). Reinforcing the
notion that MEPP amplitudes are larger in VAChTHyp
animals compared to controls, the cumulative probabil-
ity plot (Fig. 2d) shows a shift to the right in the
VAChTHyp curve (P < 0.001, Kolmogorov-Smirnov).
These findings demonstrate that VAChT overexpression
Fig. 1 VAChT transcripts are increased in the spinal cord of VAChThyp compared to control mice (a). VAChT protein is also increased in motor
axon nerve endings innervating skeletal muscles in VAChTHyp compared to control mice (b–d). Only male mice on a C57BL/6 background were
used in these experiments. For qPCR, animals were 83 days old (n = 4 for control; n = 4 VAChThyp). For NMJ analysis, animals were 9 days old
(n = 4 for control; n = 4 VAChThyp). Scale bar = 10 μm. Error bar = Standard Error. **P value <0.01
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augments the amount of ACh loaded into and released
from synaptic vesicles at NMJs.
Normal development of NMJs in VAChTHyp mice
Several lines of evidence indicate that ACh acts as an anti-
synaptogenic factor at NMJs [4, 5, 7]. We thus asked if in-
creased ACh levels affect developing NMJs in the predom-
inantly fast-twitch EDL muscle. To facilitate analysis of
motor nerve endings, we generated VAChTHyp mice ex-
pressing tdTomato specifically in cholinergic neurons.
This was accomplished by mating VAChTHyp mice
with ChAT-IRES-Cre [17] and tdTomato [18] mice.
Control and VAChTHyp mice are referred herein as
ChAT-Cre;tdTomato and VAChTHyp;ChAT-Cre;tdTo-
mato, respectively. To ascertain that VAChT expres-
sion is not affected by expression of Cre from the
ChAT (Chat-Cre) locus and tdTomato from the Rosa
locus (tdTomato), we examined VAChT mRNA levels
in the spinal cord of wild-type, Chat-Cre;tdTomato,
and VAChTHyp;Chat-Cre;tdTomato mice. While VAChT
transcripts were significantly elevated in the spinal cord of
VAChTHyp;Chat-Cre;tdTomato mice, there was no differ-
ence between wild-type and Chat-Cre;tdTomato mice
(Fig. 3h). We thus used VAChTHyp and control mice ex-
pressing tdTomato to examine NMJs at postnatal day 9
(P9). At this age, NMJs are still in the process of
developing from a small plaque, often occupied by mul-
tiple innervating α-motor nerve endings, to a large
pretzel-like structure [22]. We found that increased
VAChT expression had no effect on the development of
NMJs. The size of AChR clusters, the percent apposition
between pre- and postsynaptic sites, and the incidence of
multiply innervated NMJs are similar in the EDL muscle
of VAChTHyp and control mice (Fig. 3a–e). Next, we asked
if increased ACh affects expression of the gamma and ep-
silon subunits of AChRs in developing EDL muscles. The
epsilon subunit replaces the gamma subunit as NMJs
mature [23], altering the functional properties of
AChRs [24, 25], and thus serves as a functional
marker for maturing NMJs. Our analysis revealed
similar levels of both the gamma and epsilon subunits
in VAChTHyp mice compared to control mice of the
same age (Fig. 3f ). Collectively, these findings demon-
strate that the structural and functional maturation of the
NMJ are unaffected by higher levels of synaptic ACh.
Nerve activity has been well documented to influence
the maturation and specification of muscle fiber types
[26]. There are four major types of skeletal muscle fibers
that can be identified based on their expression of myosin
heavy chain (MyHC) isoforms (type 1, 2A, 2X, or 2B) [27].
We thus asked if altering levels of ACh affect muscle bio-
genesis, independently of changes at NMJs. In the tibialis
Fig. 2 The impact of increasing ACh was determined by recording miniature endplate potentials (MEPPs) in the diaphragm of young adult
control and VAChTHyp mice. The frequency of MEPPs is unchanged in VAChTHyp mice (a), with error bar representing the standard error. However,
the average MEPP amplitude is higher in VAChTHyp (n = 2297 events) compared to that in control mice (n = 2444 events) (b–d). The amplitude of
MEPPs was on average significantly higher in VAChTHyp mice using a Kolmogorov-Smirnov test (d; P value <0.001). Results are from 50 muscle fibers
from five mice per genotype. Error bar = Standard Error. Four-month-old male mice on a C57BL/6 background were used for these experiments
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anterior (TA) and EDL muscles of 9-day-old VAChTHyp
mice, mRNA levels for MyHC type 2A, 2B, and 2X were
similar to those in control mice (Fig. 3g). These findings
show that the increased level of synaptic ACh in
VAChTHyp does not alter the normal development of
muscle fibers and NMJs in the TA and EDL muscles.
NMJs exhibit age-related changes in young adult
VAChTHyp mice
In adulthood, the NMJ undergoes functional and struc-
tural changes due to diseases, injury, aging, and exercise
[19, 28]. Since all these different conditions inevitably
affect cholinergic transmission, we assessed the impact of
moderately increasing synaptic ACh on adult NMJs. In
the EDL muscle of 1-, 5-, and 19-month-old VAChTHyp
and aged-matched control mice, we examined NMJs for
fragmentation, denervation, sprouting of motor axon
nerve endings, and innervation by multiple motor axons.
These cellular characteristics are a hallmark of NMJs in
aged EDL muscles. We thus refer to them as age-related
structural features. In 1-month-old male VAChTHyp mice,
there was no change in the number of fragmented and de-
nervated NMJs compared to control mice of the same age
and sex (Fig. 4a, b, e, f ). However, NMJs were often found
multiply innervated (Fig. 4g) and with motor axons
sprounting beyond the postsynaptic site (Fig. 4h) in 1-
month-old VAChTHyp mice. By 5 months of age, frag-
mented and denervated NMJs were more prevalent in
male VAChTHyp mice (Fig. 4d–f ) compared to age- and
sex-matched control and 1-month-old VAChTHyp mice
(Fig. 4c, e, f ). The number of multiply innervated NMJs
and axons sprouting beyond the postsynaptic site
was similar between 1- and 5-month-old VAChTHyp mice
(Fig. 4g, h). NMJs were similarly affected in 5-month-old
female VAChTHyp mice (Fig 4i–l). At 19 months of age,
the incidence of NMJs with deleterious age-related struc-
tural changes further increased in female VAChTHyp mice
compared to control mice (Fig. 5a–d). Contrary to our ex-
pectations, these findings show that moderately increasing
synaptic ACh accelerates aging of NMJs.
We next asked if structural alterations at NMJs in
VAChTHyp mice are the result of changes in key molecules
with critical functions at NMJs. For this, we examined
mRNA levels for eight NMJ-associated molecules in the
EDL muscle of 5- and 19-month-old mice. Although
acetylcholinesterase (AChE) was expressed at similar
levels in the EDL muscle of 5-month-old control and
VAChTHyp mice, AChE was significantly reduced in aged
VAChTHyp (Fig. 6a). In contrast, mRNA for the gamma
and epsilon nicotinic AChR subunits (Fig. 6b, c) [29], the
muscle-specific kinase (MuSK) (Fig. 6d) [30], the LDL
receptor-related protein 4 (LRP4) (Fig. 6e), rapsyn (Fig. 6f),
the docking protein 7 (Dok7) (Fig. 6g), and the cyclin-
dependent kinase 5 (CDK5) (Fig. 6h) were unchanged in
the EDL muscle of 5- and 19-month-old VAChTHyp mice
compared to control mice of the same age.
Fig. 3 Developing NMJs are not affected in VAChTHyp mice. Multiple axons (arrowheads) innervating the same postsynaptic site in P9 EDL
muscles from control and VAChTHyp mice (a, b). Comparison of structural features revealed no discernable differences between genotypes. The
size of AChR clusters (c), apposition between the presynaptic (green in a and b) and postsynaptic apparatus (red in a and b), d and the incidence
of multiply innervating NMJs (e) were unchanged in VAChTHyp mice. Transcripts for the gamma and epsilon subunits of AChRs were also unchanged in
developing (P9) EDL and TA muscles from VAChTHyp mice (f). Similar levels of myosin heavy chains type 2A, 2B, and 2X were also found in TA + EDL of
developing (P9) control and VAChTHyp mice (g). While VAChT mRNA is elevated in the spinal cord of VAChThyp; Chat-cre;tdTom mice, it is unchanged in
the spinal cord of 3-month-old Chat-cre;tdTom mice compared to wild-type mice (h). All mice used in this study were maintained on a C57BL/6 back-
ground. The following mice were used for NMJ analysis: Ctrl = Chat-cre;tdTom and VAChTHyp = VAChThyp;Chat-cre;tdTom. At least four mice were used
for each genotype and per experiment. At least 25 NMJs per animal were examined. Scale bar = 10 μm. Error bar= Standard Error. P= 0.008
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Fig. 4 (See legend on next page.)
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NMJ degeneration precedes motor deficits in VAChTHyp mice
The accelerated aging of NMJs suggests that motor
function may be compromised in VAChTHyp mice. To
explore this possibility, we tested motor function of
5- and 13-month-old VAChTHyp and control mice by
measuring the latency to fall from a wire mesh and
from a rotating platform. At both ages, we found no
difference in body weight between genotypes (Fig. 7a, d).
At 5 months of age, VAChTHyp and control mice per-
formed equally well on both tests (Fig. 7b, c). However,
13-month-old VAChTHyp mice were unable to support
their own weight on an inverted wire mesh as long as age-
and sex-matched control mice (Fig. 7e). However, 13-
month-old VAChTHyp mice spent the same amount of
time on the rotarod as control mice of the same age
(Fig. 7f). These findings indicate that, in addition to
accelerating degeneration of NMJs, increasing synaptic
ACh compromises motor function.
NMJ degeneration precedes muscle atrophy in
VAChTHyp mice
We next examined the effect of increasing cholinergic
activity on muscle fibers’ structure and molecular com-
position. To start, we stained 14 μm muscle cross sec-
tions from the TA muscle of 5- and 19-month-old mice
with an antibody against laminin to visualize and meas-
ure the perimeter of all muscle fibers. This analysis
showed that the size of muscle fibers is unchanged in 5-
month-old VAChTHyp mice compared to control mice of
the same age (Fig. 8c, e). However, muscle fibers were
slightly smaller in 19-month-old VAChTHyp mice (Fig. 8a,
b, d, e). To determine if the reduced size of muscle fibers
(See figure on previous page.)
Fig. 4 NMJs progressively degenerate in adult VAChTHyp mice. At 1 month of age, there is an increased incidence of NMJs with age- and
disease-related structural features in the EDL muscle of VAChTHyp compared to control mice (a, b, e–h). By 5 months of age, there is an
additional increase in the number of fragmented and denervated NMJs in male (e–h) and female (i–l) VAChTHyp mice. α-motor axons
expressed tdTomato in these mice (green in a–d). Scale bar = 50 μm (a–d), 10 μm (a’–b”’). All mice used in this study were maintained
on a C57BL/6 background and only male mice were examined. Ctrl = Chat-cre;tdTom and VAChTHyp = VAChThyp;Chat-cre;tdTom. At least
four mice were used for each genotype and per experiment. Error bar = Standard Error. *P value <0.05, **P value <0.01
Fig. 5 Accelerated aging of NMJs in aging VAChTHyp mice. α-motor nerve endings (green in a and b) were visualized using an antibody against
synaptotagmin-2 (Syn-2; green). There were more fragmented and denervated NMJs found in 19-month-old VAChTHyp (b–d) compared to control
(a, c–d) mice of the same age and sex. Four mice per genotype were examined and at least 50 NMJs per animal analyzed. Scale bar = 20 μm.
Error bar = Standard Error. *P value <0.05, **P value <0.01
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in 19-month-old VAChTHyp mice is due to atrophy, we
examined the location of myonuclei using 4′,6-diami-
dino-2-phenylindole (DAPI). Myonuclei located away
from the peripheral membrane mark degenerating and
regenerating muscle fibers. In 5-month-old VAChTHyp
and control mice, all myonuclei were found adjacent to
the peripheral membrane. While a small number of
muscle fibers contained myonuclei near the middle of
the cytoplasm in 19-month-old mice, there was no dif-
ference between VAChTHyp and control mice (Fig. 8f ).
To further assess the effect of increasing synaptic ACh
on muscle fibers, we examined levels of MyHC types
2A, 2B, and 2X in the EDL muscle. Transcripts for these
genes were similarly expressed in 5- and 19-month-old
VAChTHyp and control mice (Fig. 9a–c). Moreover, levels
of myogenin, forkhead box protein O1 (Foxo1), and
Fig. 6 Analysis of NMJ-associated genes in the EDL muscle of 5- and 19-month-old control and VAChThyp mice. This analysis showed that only
AChE is altered and specifically in 19-month-old VAChThyp mice (a). Transcripts for AChRγ, AChRε, MuSK, Lrp4, rapsyn, DOK7, and CDK5 were
expressed at similar levels in the EDL muscle of VAChTHyp compared to control mice at 5 and 19 months of age (b–h). At least four female mice
per genotype maintained on a C57BL/6 background were used to compare transcript levels. Error bar = Standard Error. *P = 0.038, ***P = 0.00063
Fig. 7 VAChTHyp mice exhibit motor deficits in middle age. At 5 months of age, VAChTHyp mice do not exhibit body weight loss (a) or motor
function deficits (b, c). Thirteen-month-old VAChTHyp mice weigh the same (d) and perform equally well on a rotarod (f) as control mice of the
same age. However, the hanging test revealed motor deficits in 13-month-old VAChTHyp mice (e). Only female mice maintained on a C57BL/6
background were used for these experiments. Eight control and 12 VAChThyp mice were examined on the hanging and rotarod tests at both
ages. Error bar = Standard Error. *P value <0.05, **P value <0.01
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Fig. 8 Analysis of muscle fibers in young adult and old VAChTHyp mice. Muscle fibers were examined in VAChTHyp and control mice. Muscle fibers
in the TA muscle were stained with an antibody against laminin to visualize their size (red) and labeled with the nuclei marker, DAPI (green), to
determine if muscle fibers had undergone bouts of degeneration and regeneration (a, b). Images are from 19-month-old mice. The size of muscle
fibers is similar in 5-month-old control and VAChTHyp mice (c, e). However, muscle fibers are smaller in 19-month-old VAChTHyp mice (d, e). There
are also no significant differences in the number of muscle fibers with centrally located myonuclei between 19-month-old VAChTHyp control mice
(f). At least four female mice per genotype maintained on a C57BL/6 background were used to compare transcript levels. Scale bar = 20 μm. Error
bar = Standard Error. *P value <0.05
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Atrogin1 [31–33], markers of atrophying and regenerating
muscle fibers, were also unchanged in the EDL muscle of
VAChTHyp compared to control mice of the same age
(Fig. 9d–f ). These findings indicate that the deleterious
age-related structural features found at NMJs do not re-
sult in significant myogenic changes in VAChTHyp mice.
Presynaptic degeneration occurs in the absence of
obvious changes in motor neurons in VAChTHyp mice
We next asked if degeneration of NMJs results in loss of
motor neurons. For this purpose, we compared the
number of motor axons present in the peroneal nerve of
control and VAChTHyp mice expressing tdTomato [18]
specifically in cholinergic neurons [17]. To count motor
axons, we generated 10-μm cross sections of the com-
mon peroneal nerve, a mixed nerve that innervates the
TA, EDL, and other hind limb muscles (Fig. 10a). This
analysis revealed no difference in the number of motor
axons in 1- and 5-month-old VAChTHyp mice compared
to control mice of the same age (Fig. 10b). The total
number of peripheral axons, including sensory afferents,
was also unchanged in VAChTHyp mice (Fig. 10c).
As a response to presynaptic degeneration and in-
creased expression of VAChT, motor neurons may in-
crease expression of agrin isoforms that function to
stabilize the NMJ [34]. To explore this possibility, we ex-
amined transcripts for neural agrin isoforms (z-agrin) in
the spinal cord of 5-month-old VAChThyp and control
mice. While we found that z-agrin isoforms were not
statistically altered in the spinal cord of VAChTHyp mice
compared to control mice, it is worth noting that all
three z-agrin isoforms were moderately and consistently
higher, approximately 1.8-fold for all isoforms in
VAChTHyp mice (Fig. 10d). If motor neurons were to in-
crease these z-agrin isoforms in VAChTHyp mice, it
would likely be to stabilize nAChRs on the postsynaptic
region, and thus prevent further fragmentation and de-
nervation of NMJs. It is also plausible that overexpres-
sion of VAChT results in induction of genes involved in
the biosynthesis of ACh. This seems unlikely, however,
since the choline acetylcholine transferase (ChAT) is
expressed at similar levels in the spinal cord of
VAChTHyp and control mice (Fig. 10e). Together with
the lack of axonal degeneration, these findings indicate
that increasing synaptic ACh directly affects the struc-
tural integrity of the NMJ.
Increased cholinergic transmission accelerates ALS
pathogenesis
Early and progressive degeneration of NMJs is a hallmark
of amyotrophic lateral sclerosis (ALS) [35]. In addition,
dysregulated cholinergic transmission has become recog-
nized as a factor that exacerbates ALS-related pathologies
in mice and in cultured motor neurons [36–39]. To deter-
mine the impact of altering cholinergic transmission on
ALS-related pathological features, we crossed VAChTHyp
mice with SOD1G93A transgenic mice (SOD1G93A;-
VAChTHyp). Increasing cholinergic transmission selectively
accelerated death of male SOD1G93A mice by approxi-
mately 10 days (Fig. 11a). Although male SOD1G93A;-
VAChTHyp mice weighed the same as SOD1G93A mice
(Fig. 11c), they had diminished motor function before the
Fig. 9 Analysis of transcripts associated with muscle fiber identity (MyHC2A, MyHC2B, MyHC2B) and markers of muscle regeneration and atrophy
(Myogenin, Foxo1, Atrogin-1) revealed no change in the EDL muscle of VAChTHyp compared to control mice at 5 and 19 months of age (a–f). At
least four female mice per genotype maintained on a C57BL/6 background were used to compare transcript levels. Error bar = Standard Error
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onset of neurological symptoms (Fig. 11d, e). At 75 days of
age, male SOD1G93A;VAChTHyp mice were unable to stay
as long as the SOD1G93A mice on an inverted wire mesh, a
test that measures motor function (Fig. 11d, e). Along with
early motor deficits, we found that motor axons prema-
turely vacate NMJs in 90-day-old male SOD1G93A;-
VAChTHyp (Fig. 11f–h). These early behavioral and cellular
changes were specific to male mice; we found no differ-
ences in survival between SOD1G93A;VAChTHyp and
SOD1G93A female mice (Fig. 11b). We also found no
changes in copy numbers between SOD1G93A and SOD1-
G93A;VAChTHyp mice, strongly suggesting that increased
levels of ACh accelerate degeneration of the neuromuscu-
lar system in male SOD1G93A mice.
Discussion
Impact of increasing synaptic ACh on NMJs, muscle fibers,
and motor neurons
VAChT plays a critical role in the storage of ACh in syn-
aptic vesicles [10, 40, 41]. In VAChTHyp mice, VAChT
and ACh secretion is increased in brain tissue [9]. Our
qPCR and immunofluorescence analysis revealed that
VAChT is similarly increased in the spinal cord and at
the NMJ. Previous experiments have examined the
amount of ACh released from hippocampal slices from
these mice [9]. However, these studies did not address
whether increased expression of VAChT results in
more ACh loaded into synaptic vesicles in vivo and
in motor neurons. Our finding that MEPP amplitudes
are increased in VAChTHyp mice strongly suggests
that overexpressing VAChT increases ACh accumula-
tion in matured synaptic vesicles. These results sug-
gest that at least a population of mature synaptic
vesicles can accumulate higher amounts of ACh upon
increased levels of transporter protein. Vesicular ACh
accumulation by VAChT is complex and thought to
be tightly regulated [42]. Our data suggest that poten-
tial changes in expression or trafficking of VAChT to
synaptic vesicles can regulate the amount of ACh se-
creted by nerve endings by direct regulation of
Fig. 10 The number of motor axons and expression of molecules with critical function at the NMJ are unchanged in VAChTHyp mice. Cross
sections (10 μm) of the common peroneal nerve expressing tdTomato in motor axons were also labeled with antibodies against neurofilament
(NF) and the Schwann cell marker, S100, (a). There was no difference found in the number of motor axons (b) or peripheral axons (c) between
control and VAChTHyp mice at 1 and 5 months of age. The expression of neuronal-agrin isoforms (d) and ChAT (e) are not significantly altered in
the spinal cords of 3-month-old VAChTHyp mice. At least four male mice maintained on a C57BL/6 background were used per genotype for axonal
counts and expression analysis. Scale bar= 50 μm. Error bar = Standard Error
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neurotransmitter accumulation in synaptic vesicles. Previ-
ous reports have shown that overexpression of VAChT in
immature nerve-muscle Xenopus cultures increases both
amplitude and frequency of MEPPs. This was interpreted
as incorporation of VAChT in immature synaptic vesicles
can both increase the amount of ACh stored in vesicles as
well as increase the number of filled vesicles available for
spontaneous release [43]. We did not observe an increased
frequency of MEPPs in adult mice overexpressing VAChT,
suggesting that the population of vesicles available for
spontaneous release is unchanged in the NMJ.
In addition to its function in neurotransmission, ACh
plays a critical role in the development of the NMJ. ACh
acts as an anti-synaptogenic molecule by decreasing the
stability of AChRs, and through this activity, it is be-
lieved to function together with the neural-derived fac-
tor, z-agrin, in sculpting the NMJ [5]. In this regard,
while deletion of genes that prevent the synthesis [5, 7]
and transport [41] of ACh into synaptic vesicles cause
significant changes at NMJs, the impact of increasing
synaptic ACh levels on developing and adult NMJs had
not been examined. We now show that the rate of
synapse elimination, the size of AChR clusters, and their
apposition with presynaptic sites are unchanged in de-
veloping VAChTHyp mice. In addition, we found no dif-
ference in the development of muscle fibers. The normal
development of NMJs and muscle fibers in VAChTHyp
mice may be attributed to different factors. The add-
itional ACh released by motor neurons in VAChTHyp
mice may not change muscle action potentials as ACh is
already in excess during development [24]. Another
plausible explanation, though not necessarily mutually
exclusive, is that synaptic ACh and z-agrin are present at
saturating levels compared to nAChRs during develop-
ment. Thus, developing NMJs and muscle fibers are
likely immune to further increasing ACh at the synaptic
cleft, as is the case in VAChTHyp mice. Regarding synap-
tic elimination, all motor neurons in VAChTHyp mice are
Fig. 11 Overexpression of VAChT accelerates NMJ degeneration and death of male mice expressing SOD1G93A. The lifespan of male and female
SOD1G93A alone and crossed with VAChTHyp mice was determined. Overexpression of VAChT selectively accelerated death of male SOD1G93A mice
(a) without altering their weight (c). The average lifespan of female mice was unchanged (b). Male SOD1G93A;VAChTHyp mice also exhibited accelerated
motor deficits at 75 days of age (d, e) and accelerated NMJ degeneration at 90 days of age (f–h). All mice were maintained on a C57BL/6 background.
For survival and motor tests, SOD1G93A and SOD1G93A;VAChTHyp mice without fluorescence protein were used. Survival curves are based on as follows:
Males = 31 SOD1G93A and 21 SOD1G93A;VAChTHyp. Females = 41 SOD1G93A and 20 SOD1G93A;VAChTHyp. Motor tests were performed on 10 male
SOD1G93A and 10 male SOD1G93A;VAChTHyp mice. NMJ analysis was performed on four male mice per genotype expressing tdTomato in motor
neurons. At least 50 NMJs were examined in the EDL muscle per animal. Scale bar = 50 μm. Error bar = Standard Error. *P value <0.05
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likely to retain their “competitive vigor” [44, 45] since
ACh is likely increased by the same magnitude in all
NMJs. Hence, the time motor axons spend competing
for the same target would not be expected to change in
VAChTHyp compared to those in control mice.
In adulthood, the incidence of NMJs with deleterious
structural features increases with aging in control mice,
and those features are more pronounced in VAChTHyp
mice. These findings indicate that NMJs within the
EDL muscle vary in their susceptibility to increased
levels of ACh at the synaptic cleft. The EDL muscle is
primarily composed of muscle fibers that express my-
osin heavy chain type 2A and type 2B [28]. Thus, it is
plausible that one of these muscle fiber type is more
susceptible to increased synaptic ACh levels, a possibil-
ity not addressed in this work. Another possibility is
that NMJs receiving less resource within a motor unit
fail to adequately repair following structural changes
driven by increased ACh at their synaptic clefts. In this
regard, it has been shown that NMJs within the same
motor unit respond differently to aging [28]. It is also
possible that some motor neurons are more active,
resulting in earlier degeneration of NMJs that make up
their motor unit. Thus, an increase in the amount of
synaptic ACh together with less functional z-agrin in
adult NMJs would result in structural changes due to
increased destabilization of AChRs. However, this con-
clusion is not supported by the lack of changes in tran-
script for the gamma AChR subunit, which is closely
associated with increased internalization and degrad-
ation of AChRs. While NMJs are clearly affected in
adult VAChTHyp mice, it remains possible that choliner-
gic dysregulation elsewhere in the peripheral and cen-
tral nervous system, including the spinal cord, may
cause or contribute to the precocious degeneration of
NMJs observed in young adult VAChTHyp mice. Re-
gardless, the results in this paper do not support previ-
ous suggestions [1, 15] that decreased neuromuscular
function as a result of aging and ALS should be re-
versed by increased release of ACh at the NMJ synaptic
cleft. Instead, these findings raise the possibility that
the age-related increase in cholinergic transmission re-
ported by several published studies contribute to the
degeneration of NMJs [46–50].
It is interesting that old VAChTHyp mice present with
worse muscle function than age-matched control mice.
This is in striking contrast with better performance of
young VAChTHyp mice on the treadmill [9]. Interest-
ingly, recent analysis of the cardiac muscle in VAChTHyp
mice showed that they have preserved cardiac function
when challenged with angiotensin II, a model of heart
failure [51]. These data suggest that the better perform-
ance of VAChTHyp mice on the treadmill may be a result
of better cardiovascular fitness.
Male SOD1G93A mice are selectively susceptible to
increased ACh levels
We also showed that increasing cholinergic transmission
selectively affects male mice harboring SOD1G93A. In-
creased synaptic ACh causes NMJs to prematurely de-
generate and accelerates death of male SOD1G93A mice.
While our findings demonstrate that increasing synaptic
ACh does not affect female SOD1G93A mice, it is worth
noting that SOD1G93A mice acquire neurological symp-
toms by 90 days and die within the first 160 days of life.
Hence, it remains possible that increasing ACh at NMJs
affects the initiation and progression of ALS-related
pathology in long-lived female mice expressing mutant
genes known to cause ALS, in addition to further ex-
acerbating neurological symptoms in long-lived male
mice expressing the same mutant genes. Irrespective,
our data corroborates published findings indicating that
male animals and humans are more susceptible to ALS
[52, 53], and factors that suspect of altering the initiation
and progression of the disease [54–58].
Significance to understanding aging- and disease-related
changes at NMJs
It is now recognized that cholinergic dysfunction occurs
in neurons harboring ALS-causing mutant genes and
during normal aging [1, 35, 36, 59]. In addition, perisy-
naptic Schwann cells were recently shown to be uniquely
sensitive to altered cholinergic transmission prior to the
initiation of ALS-related symptoms in a mouse model
for the disease [37]. The identification of mutations in
cholinergic receptors in patients with ALS provides add-
itional evidence that changes in cholinergic transmission
directly drives degeneration of motor neurons and their
NMJs [38, 39, 60]. In this regard, the only FDA-
approved drug to treat ALS, riluzole, was recently shown
to bind and to block the activity of muscle nicotinic
AChRs obtained from patients with the disease [61]. The
results presented in this paper provide evidence that in-
creased cholinergic tone deteriorates NMJs in a mouse
model of ALS and during normal aging. Thus, modulation
of cholinergic transmission should be considered in ap-
proaches aimed at preventing degeneration of the motor
system during the progression of ALS and normal aging.
Conclusions
This study sought to determine the impact of increasing
synaptic ACh levels on developing, aging, and ALS-
afflicted NMJs using mice expressing multiple copies of
VAChT. We showed that while NMJs develop normally
in VAChTHyp mice, they progressively degenerate as the
mice aged. This study also revealed that destruction
of NMJs precedes degeneration of muscle fibers and
motor neurons during aging and in mice harboring
an ALS-causing mutant gene. Together, the data in
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this paper demonstrate that dysregulated levels of
ACh cause pathophysiological changes at NMJs and
contribute to loss of motor function during aging and
the progression of ALS.
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